These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 10096189)
21. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G; MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587 [TBL] [Abstract][Full Text] [Related]
22. [Emergency measures to control the spread of diseases caused by the human immunodeficiency virus]. Onishchenko GG; Beklemishcheva OA; Narkevich MI Zh Mikrobiol Epidemiol Immunobiol; 1999; (1):5-9. PubMed ID: 10096182 [TBL] [Abstract][Full Text] [Related]
23. Risk dimensions of HIV-tested substance users. Ottomanelli G Int J Addict; 1993 Dec; 28(14):1487-95. PubMed ID: 8307661 [TBL] [Abstract][Full Text] [Related]
25. [Factors associated with sharing syringes among street-recruited injecting drug users]. Folch C; Meroño M; Casabona J Med Clin (Barc); 2006 Oct; 127(14):526-32. PubMed ID: 17145000 [TBL] [Abstract][Full Text] [Related]
26. Operating needle exchange programmes in the hills of Thailand. Gray J AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363 [TBL] [Abstract][Full Text] [Related]
27. [An HIV prevalence study by means of sentinel epidemiological surveillance among injection narcotic abusers in Saint Petersburg]. Smol'skaia TT; Khodakevich LN; Kobyshcha IuV; Pimenov AS; Ostrovskiĭ DV; Shilova EA; Suvorova SV; Kotova SV; Terent'eva ZhV; Volkova GV; Makarenko GA Zh Mikrobiol Epidemiol Immunobiol; 2000; (4):31-3. PubMed ID: 10994099 [TBL] [Abstract][Full Text] [Related]
28. [The prevention of HIV infection and parenteral hepatitis among people abusing narcotics by injection in the Republic of Belarus]. Meleshko LA; Bykova VM; Brutskaia SI; Zhdanovskaia OM Zh Mikrobiol Epidemiol Immunobiol; 2000; (4):44-6. PubMed ID: 10994104 [TBL] [Abstract][Full Text] [Related]
29. [Risk behaviors for HIV transmission among the recent clients of a syringe-exchange program in Madrid, 1993]. Bravo Portela MJ; Barrio Anta G; de la Fuente de Hoz L; Colomo Gómez C; Royuela Morales L; Estébanez Estébanez P Gac Sanit; 1996; 10(57):261-73. PubMed ID: 9072510 [TBL] [Abstract][Full Text] [Related]
30. High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan. Altaf A; Saleem N; Abbas S; Muzaffar R J Pak Med Assoc; 2009 Mar; 59(3):136-40. PubMed ID: 19288936 [TBL] [Abstract][Full Text] [Related]
31. Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana. Broz D; Zibbell J; Foote C; Roseberry JC; Patel MR; Conrad C; Chapman E; Peters PJ; Needle R; McAlister C; Duwve JM Int J Drug Policy; 2018 Feb; 52():97-101. PubMed ID: 29278838 [TBL] [Abstract][Full Text] [Related]
32. [The persistence of risky conduct for HIV transmission among intravenous drug users in Madrid, Seville, and Valencia. The Working Group of the Médicos del Mundo for the Monitoring of HIV Infection and the Risk Practices of Intravenous Drug Users]. Bravo MJ; Barrio G; de la Fuente L; Colomo C; Royuela L Gac Sanit; 1999; 13(2):109-18. PubMed ID: 10356129 [TBL] [Abstract][Full Text] [Related]
33. [The joint work of NGOs and UNAIDS in realizing a project for the prevention of HIV/AIDS among people using narcotics by injection in a region with relatively low rates of HIV infection spread]. Polonets VV; Andrushchak LI Zh Mikrobiol Epidemiol Immunobiol; 2000; (4):92-3. PubMed ID: 10994121 [TBL] [Abstract][Full Text] [Related]
34. Drug injectors and dealers in Odessa, Ukraine. Booth RE; Kennedy J; Brewster T; Semerik O J Psychoactive Drugs; 2003; 35(4):419-26. PubMed ID: 14986870 [TBL] [Abstract][Full Text] [Related]
35. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; Khuê Pham M; Thi Giang H; Thi Tuyet Thanh N; Arasteh K; Feelemyer J; Hammett T; Peries M; Michel L; Vu Hai V; Roustide MJ; Moles JP; Laureillard D; Nagot N; Int J Drug Policy; 2016 Jun; 32():50-6. PubMed ID: 27006257 [TBL] [Abstract][Full Text] [Related]
36. [The comparative analysis of high-risk behaviour related to HIV infection in users of psychoactive drugs with stimulating action and opioids]. Titova EA; Krupitskiĭ EM; Shtakel'berg OIu; Grinenko AIa Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 2):74-9. PubMed ID: 21322150 [TBL] [Abstract][Full Text] [Related]
37. Syringe and needle exchange programs: Part I. Schwartz RH South Med J; 1993 Mar; 86(3):318-22. PubMed ID: 8451672 [TBL] [Abstract][Full Text] [Related]
38. [Intravenous drug use and the spread of HIV; an international perspective]. Meijerink H; van Crevel R; van der Ven AJ Ned Tijdschr Geneeskd; 2013; 157(21):A5690. PubMed ID: 23693006 [TBL] [Abstract][Full Text] [Related]
39. [Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected--7 percent have HIV, as demonstrated by the first baseline study]. Hillgren K; Sarkar K; Elofsson S; Britton S Lakartidningen; 2012 Jun 19-26; 109(25):1221-5. PubMed ID: 22838111 [No Abstract] [Full Text] [Related]
40. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW). Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]